Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Recovery

News
Medication to Treat Alcohol Use Disorder Shows Promise in Phase 3 Trial
07/28/2022
Adial Pharmaceuticals announced that in its ONWARD Phase 3 clinical study, its AD04 medication achieved a statistically significant mean reduction in heavy drinking days among a prespecified group of “heavy drinkers” compared to a placebo.
Adial Pharmaceuticals announced that in its ONWARD Phase 3 clinical study, its AD04 medication achieved a statistically significant mean reduction in heavy drinking days among a prespecified group of “heavy drinkers” compared to a placebo.
Adial Pharmaceuticals announced...
07/28/2022
Psych Congress Network
Wendy Insalaco, MS, LGPC, LGADC, ICCDPD, ACRPS, ICCS
Perspectives
3 Steps for Relapse Prevention and Long-Term Treatment Success
07/22/2022
Recognizing relapse triggers, minimizing high-risk situations, and developing an individualized relapse prevention plan are important to maintain progress in recovery.
Recognizing relapse triggers, minimizing high-risk situations, and developing an individualized relapse prevention plan are important to maintain progress in recovery.
Recognizing relapse triggers,...
07/22/2022
Addiction Professional
News
CODAC Launches Mobile Unit to Facilitate Medication-Assisted Treatment
07/19/2022
CODAC Behavioral Healthcare, a not-for-profit provider of outpatient opioid treatment in Rhode Island, announced on Monday that it has launched a mobile medical unit to dispense methadone, buprenorphine, and naltrexone for opioid use disorder...
CODAC Behavioral Healthcare, a not-for-profit provider of outpatient opioid treatment in Rhode Island, announced on Monday that it has launched a mobile medical unit to dispense methadone, buprenorphine, and naltrexone for opioid use disorder...
CODAC Behavioral Healthcare, a...
07/19/2022
Addiction Professional
News
Young Adults Filled Fewer Buprenorphine Prescriptions After Pandemic Started
07/12/2022
Buprenorphine prescriptions for young adults paid for by commercial insurance or cash, but not Medicaid, significantly decreased in the early months of the COVID-19 pandemic, according to a recent study.
Buprenorphine prescriptions for young adults paid for by commercial insurance or cash, but not Medicaid, significantly decreased in the early months of the COVID-19 pandemic, according to a recent study.
Buprenorphine prescriptions for...
07/12/2022
Addiction Professional
News
Longer MAT Engagement Linked With Better Outcomes for OUD Patients
06/15/2022
The longer individuals with opioid use disorder engage in medication-assisted treatment, the less likely they are to overdose, according to a new study of Medicaid beneficiaries.
The longer individuals with opioid use disorder engage in medication-assisted treatment, the less likely they are to overdose, according to a new study of Medicaid beneficiaries.
The longer individuals with...
06/15/2022
Addiction Professional
News
Pandemic-Related Buprenorphine Prescribing Changes Linked With Improved Outcomes
06/08/2022
COVID-19-related changes to buprenorphine prescribing guidelines improved opioid use disorder patient outcomes, according to Drexel University researchers.
COVID-19-related changes to buprenorphine prescribing guidelines improved opioid use disorder patient outcomes, according to Drexel University researchers.
COVID-19-related changes to...
06/08/2022
Psych Congress Network
News
Thoughtful Approach Enhances Care in Group Treatment Settings
06/05/2022
West Coast Symposium on Addictive Disorders presenter Andrew Kurtz, MA, LMFT, discusses improving engagement in group treatment settings and keys for building a framework for recovery support services.
West Coast Symposium on Addictive Disorders presenter Andrew Kurtz, MA, LMFT, discusses improving engagement in group treatment settings and keys for building a framework for recovery support services.
West Coast Symposium on...
06/05/2022
Addiction Professional
News
Brain Retraining Plays Key Role in SUD Recovery
06/02/2022
West Coast Symposium presenter Siobhan Morse, MHA, UHS director of clinical services and project manager for substance use disorders, explains how brain retraining fits into a recovery plan.
West Coast Symposium presenter Siobhan Morse, MHA, UHS director of clinical services and project manager for substance use disorders, explains how brain retraining fits into a recovery plan.
West Coast Symposium presenter...
06/02/2022
Addiction Professional
Ryan Drzewiecki, PsyD, LP
Perspectives
While Often Helpful, Beware of Technology’s Potential for Misuse in Recovery
05/29/2022
Key markers of clients’ digital media consumption, including social media, video games, and TV viewing, should be assessed for signs of addiction.
Key markers of clients’ digital media consumption, including social media, video games, and TV viewing, should be assessed for signs of addiction.
Key markers of clients’ digital...
05/29/2022
Addiction Professional
News
Researchers Receive NIDA Grant to Study Nonhallucinogenic Compounds to Treat SUD
05/27/2022
Researchers from the University of California, Davis, and the University of Colorado Anschutz Medical Campus will screen hundreds of compounds.
Researchers from the University of California, Davis, and the University of Colorado Anschutz Medical Campus will screen hundreds of compounds.
Researchers from the University...
05/27/2022
Psych Congress Network

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement